Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1990-6-7
pubmed:abstractText
1. The single-channel current recording technique has been used to investigate the effects of cromakalim, diazoxide and ATP, separately and combined, on the opening of ATP-sensitive potassium channels in the insulin-secreting cell-line RINm5F. The actions of these drugs have been studied using the permeabilized open-cell variation of the patch-clamp technique. 2. In the absence of internal ATP, cromakalim (80-200 microM) was unable to open ATP-sensitive K+ channels but when ATP was present both cromakalim and diazoxide caused channel openings. 3. Interactions between ATP and cromakalim seemed competitive. Concentrations of cromakalim in the range 80-200 microM readily activated channels inhibited by 0.1 mM ATP, but had no effects when the concentration of ATP was increased to 0.5-2 mM. Only when the concentration of cromakalim was increased to 400-800 microM could opening of 0.5-2 mM ATP-inhibited channels be regularly observed. In the continued presence of cromakalim (400-800 microM), an increase in the internal concentration of ATP from either 0.25 to 0.5 mM or 1 to 2 mM, inhibited cromakalim-activated K+ channels. 4. Activation of ATP-inhibited K+ channels was abolished by replacing ATP with ATP gamma S and cromakalin had no effects on ATP gamma S-inhibited channels. This suggests that cromakalim may open KATP channels in insulin-secreting cells by a mechanism which involves protein phosphorylation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2412077, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2412127, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2417189, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2419566, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2423172, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2428009, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2429868, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2429869, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2430658, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2431383, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2434654, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2436138, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2440431, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2442362, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2447283, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2452099, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2456760, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2460868, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2464055, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2470586, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2546174, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2666156, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-2674891, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3049931, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3050116, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3056715, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3057214, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3072727, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3107454, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3666042, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-3708211, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6086910, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6090930, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6092641, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6095103, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6131003, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-6310409, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-7046755, http://linkedlifedata.com/resource/pubmed/commentcorrection/2184910-908462
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
169-75
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells.
pubmed:affiliation
Physiological Laboratory, University of Liverpool.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't